Regulations Archives - Page 92 of 193

2 minute read

EXCLUSIVE: How Federal Cannabis Reclassification Could Transform Business Finances, Insights From Cresco Labs’ CEO

September 5, 4:31 PM

"It's a watershed moment for cannabis," declared Charlie Batchell, the CEO and co-founder of Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), during an illuminating conversation with Aaron Bry,

CSE:CL

2 minute read

EXCLUSIVE: Cannabis Tipping Point, Verano CEO Weighs In On HHS Rescheduling Proposal

By Joana Scopel

September 5, 3:08 PM

"This is a big moment for us," says George Archos, CEO of Verano Holdings Corp (CSE: VRNO)(OTCQX: VRNOF), in light of the recent announcement where the Department of Health and Human Services (HHS) recommended the Drug Enforcement Administration (DEA) to

CSE:VRNO

3 minute read

Is Federal Cannabis Legalization A Double-Edged Sword? The Answer Is Complicated

By Joana Scopel

September 5, 2:37 PM

"The real catalyst is going to be federal legalization.

NLCP

1 minute read

China’s Bold $40B Chip Investment Challenges Nvidia, Signals Resilience Against US Embargo

By Anusuya Lahiri

September 5, 10:13 AM

China's $40 billion state fund to boost the chip industry is a massive shoutout regarding the country's plans not to yield to the U.S.

AMD

2 minute read

Why Facebook News is Shutting Down in Europe: What It Means for Users?

By Anusuya Lahiri

September 5, 10:01 AM

Today, Meta Platforms Inc (NASDAQ: META) announced a significant development regarding Facebook News in the U.K., France, and Germany. The dedicated news tab on Facebook, known as Facebook News, will cease to exist in early December.

GOOG

1 minute read

What’s Going On With Nvidia Stock Tuesday?

By Anusuya Lahiri

September 5, 9:36 AM

Nvidia Corp (NASDAQ: NVDA) is trading lower Tuesday in line with the broader indexes Invesco QQQ Trust, Series 1 (NASDAQ:

AAPL

1 minute read

Cybin Announces Grant of US Patent Covering Deuterated Tryptamines

By Benzinga Newsdesk

September 5, 7:31 AM

Cybin Inc. (NYSE:CYBN) (NEO:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative

CYBN

1 minute read

uniQure Wins FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe Epilepsy

By Benzinga Newsdesk

September 5, 7:06 AM

uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the U.S. Food and Drug Administration (FDA) has cleared the

QURE

2 minute read

Medical Marijuana Giants Lambaste NY Gov. Hochul For Weed Rollout Mess, Seek Licenses To Sell Recreational Weed

By Maureen Meehan

September 4, 11:45 AM

Four major medical marijuana retailers in New York sent a letter to Gov.

ACRHF

2 minute read

Economic Data Takes Pressure Off Fed For Another Rate Hike, SEC Loses Court Fight Over Bitcoin ETF, Cannabis Stocks Rally With Drug’s DEA Classification Under Review: The Week In The Markets

By Dustin Blitchok

September 1, 4:10 PM

Only 7% of traders are anticipating an interest rate hike at the Federal Reserve’s September meeting in the wake of inflation data this week that met economist expectations and an August jobs report that reflects a growing equilibrium of supply and demand